key: cord-1002094-zfldepki authors: Abdullah, Ibtisam; Cornelissen, Helena M.; Musekwa, Ernest; Zemlin, Annalise; Jalavu, Thumeka; Mashigo, Nomusa; Chetty, Carissa; Nkosi, Nokwazi; Chapanduka, Zivanai C. title: Hematological findings in adult patients with SARS CoV‐2 infection at Tygerberg Hospital Cape Town South Africa date: 2022-04-13 journal: Health Sci Rep DOI: 10.1002/hsr2.550 sha: e1142c7d30fbfd3be5157ced944b769240baff77 doc_id: 1002094 cord_uid: zfldepki BACKGROUND: Coronavirus disease 2019 (COVID‐19) is associated with hematological abnormalities of variable severity. The full blood count (FBC) and leukocyte differential count (DIFF) could facilitate the prediction of disease severity and outcome in COVID‐19. This study aimed to assess the hematological parameters in early severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and their correlation with disease outcome. METHODS: A retrospective cross‐sectional descriptive study was performed. Adults with a FBC and positive SARS‐CoV‐2 polymerase chain reaction results between March 1, and June 31, 2020 were reviewed. Basic hematological parameters (FBC, DIFF) and human immunodeficiency virus (HIV) status were recorded. Outcome measures were admission to a general ward or intensive care unit (ICU), recovery or death. RESULTS: Six hundred and eighty‐five cases median age 51 years, were analyzed. Forty‐four percent were males and fourteen percent were HIV‐positive with no association between death and/or ICU admission (p = 0.522 and p = 0.830, respectively). Leucocytosis was predictive of ICU admission (odds ratio [OR]: 2.4, confidence interval [CI]: 1.77–3.8186) and neutrophilia, of both mortality (OR: 1.5, CI: 1.0440–2.0899) and ICU admission (OR: 4, CI: 2.5933–6.475). Median lymphocyte count was decreased and d‐dimer raised, showing no significant association with outcome. Raised neutrophil‐to‐lymphocyte‐ratio (NLR) was associated with increased odds of mortality (OR: 2.5, CI: 1.3556–3.2503) and ICU admission (OR: 4.8, CI: 2.4307–9.5430) as was monocyte‐to‐lymphocyte‐ratio (MLR) (OR: 2, CI: 1.3132–2.9064) and (OR: 2.3, CI: 1.0608–1.9935), respectively. Hospital admission and older age were significantly associated with mortality (p = 0.0008 and p < 0.0001), respectively. CONCLUSION: Evidence‐based interpretation of routine laboratory parameters, readily available in resource‐constrained settings, may identify patients at increased risk of mortality. The FBC, DIFF, NLR, and MLR should form part of the early COVID‐19 investigation. Since the first cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the emergence of the ensuing global pandemic, there has been an exponential increase in the understanding of the virus, its clinical presentation, laboratory features and management. [1] [2] [3] [4] [5] Coronavirus disease 2019 (COVID-19) is associated with multisystem complications and hematological abnormalities of variable severity. [4] [5] [6] The correlation between early changes in hematological parameters and disease outcome, is under active investigation. 4, 5, [7] [8] [9] Hematological changes reported include changes in full blood count (FBC) parameters, abnormal morphological characteristics of blood cells on peripheral blood smear examination and derangement of hemostatic parameters, referred to as COVID-19-associated coagulopathy (CAC). 4,7,10 FBC findings associated with SARS-CoV-2 infection include anemia, neutrophilia, lymphopenia, monocytosis, eosinopenia, mild thrombocytopenia, and less frequently thrombocytosis. 2, 4, 5, 7, 9 Lymphopenia, increased platelet-to-lymphocyte ratio, increased neutrophil-to-lymphocyte ratio (NLR), low B lymphocytes, low CD8-positive T lymphocytes, and elevated CD4/CD8 ratio have been associated with adverse disease outcomes. [11] [12] [13] Changes reported on peripheral blood smears are predominantly nonspecific features seen in infective/inflammatory states. 7 Reported coagulation parameter changes include elevated D-dimer and fibrinogen levels with relatively normal partial thromboplastin time (PTT) and thrombin time. [13] [14] [15] [16] However, coagulation parameters are dynamic and differ depending on the severity of disease and coagulopathy. 16 Coagulopathy is associated with increased mortality. 10, 16, 17 South Africa's diverse ethnicity and socioeconomic status of its inhabitants pose a particular challenge in terms of predicting the epidemiological and clinicopathological features of COVID- 19 . The burden of the human immunodeficiency virus (HIV) and tuberculosis (TB) infections, compounded by the high prevalence of noncommunicable diseases, increase the difficulty in extrapolating data from other COVID-19 ravaged countries, to the South African situation. Widely available routine basic laboratory parameters, accessible in low resource settings could facilitate prediction of disease severity and outcome in COVID-19. 5, 9, 18 This study aimed to assess the hematological parameters in early COVID-19 and their correlation with outcome in a resourceconstrained setting. The study is a retrospective cross-sectional descriptive study performed at the National Health Laboratory Service (NHLS), Tygerberg Seven hundred and thirty-eight SARS-CoV-2 cases were initially included, and fifty-three cases were excluded. Excluded cases did not have an FBC after the collection of positive SARS-CoV2 test or had an FBC result after recovery (see Figure 1 ). The median and IQR of laboratory parameters of the total group is summarized in Table 1 and the odds ratio (OR) in Table 2 . A total of 685 cases were analyzed; 656 (96%) were admitted of which 150 (22%) were ICU admissions and 29 (4%) were outpatients. About 14% of the cases were HIV-positive, 65% were HIV-negative and the HIV status of 21%, was unknown. HIV-positive status was not significantly associated with death (p = 0.521). Male gender was significantly associated with ICU admission (p = 0.007) but not with death overall (p = 0.522) or death in ICU (p = 0.157; see Table 3 ). The majority of recoveries were in the 18-39 years age group while most deaths were in the 50-59 years age group (see Figure 2 ). The median age of deceased patients was 53 years compared to 49 years in the recovered group. ICU admission (mean: 51.347, SD: 11.494; p < 0.001) and death (mean: 52.078, SD: 13.113; p < 0.001) were significantly associated with older age. Tables 1 and 2 ). This study evaluated the available hematology laboratory results and demographic data in a tertiary public healthcare facility in South Africa and their relation to ICU admission, death, length of hospital Odds of admission to intensive care unit (ICU) compared to general ward according to total white cell count (WCC). (B) Odds of admission to general ward compared to intensive care unit (ICU) according to neutrophil-to-lymphocyte ratio (NLR). Both leucocytosis and raised NLR were associated with increased odds of ICU admission F I G U R E 4 Receiver operating characteristic curves for neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) and association with death. A raised NLR (optimal cut-off of >4.04) showed a higher sensitivity for death while MLR (cut-off > 0.68) showed higher specificity for death. AUC, area under the ROC curve and recovery in patients diagnosed with COVID-19 over a 3-month period. Similar to previously published studies, advanced patient age at presentation was directly associated with worse outcomes in this cohort (see Figure 2 ). Adults older than 70 years represent only 13.6% of the Western Cape Province population. 20, 21 Disproportionately, the highest death frequency was noted in patients above the age of 70 years (36.6%), which is similar to the findings of other studies during the first wave of the COVID-19 pandemic. 1, 22 The overall COVID-19 mortality rate in South Africa in July 2020 was 1.7% which is considerably lower than the figure Italy reported during the first wave of the pandemic, 15.2%. 21, 23 In comparison to Italian demographics, the South African population is younger which may be a significant contributory factor to the comparatively better South African outcomes despite the more advanced healthcare system in Italy. 23 The mortality was increased in the HIV-positive group in our study; however, this was not statistically significant, probably due to the small number in this cohort. Viral suppression and anti-retroviral Hematological parameters that were associated with worse outcomes in our study included leucocytosis and neutrophilia in particular. Higher leukocyte counts have been associated with increased mortality in COVID-19. 3 Monocytes play an important role in the innate immune response to infection and elevated counts have been reported in COVID-19. 3, 28 An increased MLR was associated with both death and ICU admission. Platelet production by megakaryocytes is regulated mainly shown contradicting findings. 22, 27 In early SARS-CoV2 infection, platelet counts have not correlated with the outcome which probably explains the normal platelet count in this cohort. 5, 9, 36 Anemia could develop during the course of COVID-19 either due to direct SARS-CoV-2 infection, iatrogenic blood loss during admission, or dysregulation of iron metabolism. 5 with increased odds of developing severe disease at time of presentation. The limitations of this study include its retrospective nature and contributes to an uncontrolled risk of selection bias as some patients may have presented for the first time at a late stage of the disease. Only data from the NHLS LIS was used, with limited access to clinical data. The observed association between laboratory parameters and outcome may be confounded by clinical factors including various therapeutic modalities, such as lymphopenia due to the use of corticosteroid or the effect of ARV management on the degree of immune suppression or CD4 count in HIV-positive group. This study highlights the use of affordable and widely available laboratory tests in assessment of COVID-19 in the South African setting. It was found that advanced patient age, leucocytosis, neutrophilia, raised NLR, and MLR are significantly associated with worse COVID-19 outcome. These parameters form part of routine testing in public healthcare facilities in South Africa and other resourceconstrained settings and therefore could be used as early indicators of disease severity. It is recommended that the FBC and differential count, NLR and MLR should form part of early clinical assessment in COVID-19 infection. The authors would like to acknowledge the Tygerberg Hospital NHLS The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request. Clinical characteristics of coronavirus disease 2019 in China Hematologic parameters in patients with COVID-19 infection Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series Haematological manifestations of COVID-19: from cytopenia to coagulopathy Overview of the haematological effects of COVID-19 infection Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study The pathophysiology of the haematological manifestations of COVID-19: a review Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis COVID-19 and the clinical hematology laboratory Thromboinflammation and the hypercoagulability of COVID-19 Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19 Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study Role of hematological parameters in the stratification of COVID-19 disease severity Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis Hematological findings and complications of COVID-19 COVID-19 and its implications for thrombosis and anticoagulation COVID-19 and its implications for thrombosis and anticoagulation Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Role of time-normalized laboratory findings in predicting COVID-19 outcome Research Electronic Data Capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa Western Cape Government COVID-19 statistics Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan Midyear Population Estimate Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort Factors associated with COVID-19-related death using OpenSAFELY Why aren't people living with HIV at higher risk for developing severe coronavirus disease 2019 (COVID-19)? Clinical characteristics of refractory coronavirus disease COVID-19 and neutrophils: the relationship between hyperinflammation and neutrophil extracellular traps Clinical features of patients infected with 2019 novel coronavirus in Wuhan Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients Mechanisms of lymphocyte loss in SARS coronavirus infection Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study COVID-19 related laboratory analyte changes and the relationship between SARS-CoV-2 and HIV, TB and HbA1c in South Africa Red cell distribution width (RDW): a prognostic indicator of severe COVID-19 Anemia is associated with severe illness in COVID-19: a retrospective cohort study